AQST - Company ID 0001398733
The table below shows Aquestive Therapeutics, Inc.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q3 2026 | Q2 2026 | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $90.35M | $98.49M | $110.73M | $129.06M | $60.54M | $68.66M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | - | - | - | - | - | - |
| Inventory | $7.31M | $7.37M | $8.07M | $7.88M | $8.13M | $7.20M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $105.83M |
| $118.49M |
| $130.18M |
| $151.67M |
| $81.72M |
| $89.17M |
| Property, plant & equipment | $4.36M | $3.96M | $3.84M | $3.92M | $3.86M | $3.80M |
| Goodwill | - | - | - | - | - | - |
| Total assets | $119.33M | $132.10M | $141.13M | $163.56M | $93.70M | $102.23M |
| Accounts payable | $8.82M | $8.96M | $11.89M | $10.87M | $11.95M | $12.28M |
| Total current liabilities | $17.30M | $16.48M | $31.75M | $25.57M | $23.16M | $18.30M |
| Long-term debt | $55.00M | $55.00M | $45.00M | $45.00M | $45.00M | $45.00M |
| Total liabilities | $190.15M | $188.69M | $175.18M | $167.67M | $166.29M | $163.16M |
| Retained earnings | -$494.42M | -$477.92M | -$455.06M | -$415.14M | -$399.69M | -$386.14M |
| Total equity | -$70.82M | -$56.59M | -$34.05M | -$4.11M | -$72.59M | -$60.93M |